We're thrilled to announce that our Alzheimer's Fast Track 2025 workshop is being as the AARP Brain Health Action Collaborative Action of the Week! By connecting early-career scientists with leading experts, we’re igniting new ideas to advance Alzheimer's research: https://bit.ly/3MOcThQ.

🌍 Smart science knows no borders! BrightFocus Foundation is funding innovative research across 16 countries, supporting 186 projects that are advancing our understanding of Alzheimer's, macular degeneration, and glaucoma. Explore our 2025 research portfolios: https://bit.ly/4sa1OrC

🧠 Researchers have identified a promising new class of blood biomarkers known as circular RNAs (circRNAs) for early Alzheimer's detection. Read more : https://bit.ly/3N7zR3m

BrightFocus Foundation Alzheimer’s Disease Research grant recipient Dr. Hongjun Fu grows “mini-brains” to study why certain neurons are vulnerable in Alzheimer’s & PSP. These images show brain tissue at 60 days (left) and 120 days (right). Read more about Dr. Fu’s project: https://bit.ly/4s29wnt

The EVOKE trials found that semaglutide, the GLP-1 drug behind several popular diabetes and weight loss medications, did not meaningfully slow cognitive decline in people with Alzheimer’s disease. Explore this research and more news from #CTAD2025. https://bit.ly/48KgAxG

Did you know some people maintain sharp thinking skills even with Alzheimer's-related brain changes? Building cognitive reserve through lifelong learning, social connections, and healthy lifestyle choices may help protect your brain. Learn more: https://bit.ly/3MmMgAo

New study results indicate that lifestyle changes can protect aging brains. The U.S. POINTER study tested whether a structured, healthy lifestyle program could protect cognitive function in at-risk older adults. The answer is YES. Explore this news and more from #CTAD2025: https://bit.ly/4pTAgoa

🔬 $28.4 million. 🧠 111 projects. 🌍 13 countries. BrightFocus Foundation’s is funding bold ideas and cutting-edge research that could lead to ways to prevent, treat, and ultimately cure Alzheimer’s for the 7+ million Americans living with it. Explore the science: https://bit.ly/48HvKlM

Can Alzheimer's be stopped before it starts? The AHEAD Study is exploring that question. On Dec 18, Dr. Joshua Grill will explain how researchers are testing Leqembi in people at elevated risk for Alzheimer's—targeting brain changes years before symptoms emerge. Register now: https://bit.ly/4oEVZzm

A scientist funded by BrightFocus Foundation found a link between macular degeneration & Parkinson’s—a finding that led to the development of a new supplement to help protect sight. Now, he’s searching for new treatments that could benefit millions facing vision loss: https://bit.ly/4adXAsb.

The landscape of Alzheimer’s disease treatments is shifting. Dr. Marwan Sabbagh will join us to discuss the emerging therapies now in development—including disease-modifying drugs that target the underlying biology of Alzheimer’s. Join us TODAY at 1 pm ET: https://www.youtube.com/live/e_o2GsmiFTA

🚀 Exciting news! BrightFocus Foundation sponsored travel for 39 early-career scientists to attend @sfn.org's annual meeting in San Diego, and for many, it was their first time at the conference! 📸: A few of BrightFocus Foundation's travel grantees at #SfN2025.

In recognition of #NationalCaregiversMonth, our Nov Macular Chat will explore the role of caring for an individual with vision loss. Our guest experts will discuss the realities of caregiving, financial challenges, practical resources & support. 🎧 Tomorrow @ 1pm ET: BrightFocus.org/LiveChatMDR

💬✨🧠🌟Wrapping up an incredible Alzheimer’s Fast Track workshop! We’re truly inspired by the brilliant minds that gathered in San Diego to explore breakthrough ideas in Alzheimer's disease research. Exciting times ahead as we gear up for #SfN25! Special thanks to this year’s co-chairs and speakers!

Happening tomorrow: Get your glaucoma questions answered. Dr. Poonam Misra of Manhattan Eye, Ear & Throat Hospital joins our Glaucoma Chat at 1 p.m. ET for a live conversation. She’ll cover frequently asked questions about glaucoma. Listen live tomorrow: https://bit.ly/4nz3KGw

When Dave Palmer's father lost vision to age-related macular degeneration, Dave and his wife Leanna wanted to help. They started supporting Macular Degeneration Research at BrightFocus Foundation. See the impact of donor support in our 2025 annual report: https://bit.ly/4o6LuFF.

A surprising connection: Parkinson's drug L-DOPA protects against age-related macular degeneration (AMD). Researcher Brian McKay, PhD, used this finding to discover a protective eye pathway & create an AMD supplement. Now he's working on new treatments based on this discovery. 🔬

Join us for our next Glaucoma Chat on Nov. 12 at 1 pm ET, featuring Dr. Poonam Misra, a glaucoma specialist & fellowship co-director at Manhattan Eye, Ear & Throat Hospital, who'll address some of the most common questions listeners have shared over the past year. Register: https://bit.ly/3WDDLTn

"If you can't help the one you love, help the one you can." When the Sahyun family faced both vision loss & dementia diagnoses, this advice transformed their heartbreak into hope. Read about how they—and other families—are fueling Alzheimer’s research in our annual report: https://bit.ly/4ovA8L6

Join our Macular Chat tomorrow, October 29, with Dr. Jeffrey Stern, co-founder of the Neural Stem Cell Institute. He'll cover the latest science, share clinical trial updates, and explain what these advances mean for people living with AMD. Listen live. 🔊 ↘️

🧠 New infographic: FDA-approved Alzheimer's treatments at a glance—how they work, administration methods, and which disease stages they target. View it here: https://bit.ly/42Ziuaq Made possible by sponsorships from Eisai and Lilly.

🧠 Did you know your gut health could impact your Alzheimer's risk? Join Dr. Beau Ances from @WashU today (Oct 21) at 1 p.m. ET as he breaks down the emerging science connecting trillions of gut bacteria to brain health. Watch live and get your questions answered. ⤵️

New research is exploring how to restore vision after glaucoma damage. Dr. Lucy Q. Shen breaks down the science and shares what makes her hopeful about the future of treatment. 🔊 Listen here: https://bit.ly/47aaLau #GlaucomaChat #Glaucoma #BrightFocusFoundation

Could gut bacteria affect your brain? 🧠🦠 Join Dr. Beau Ances Oct 21 at 1 p.m. ET to explore the gut-Alzheimer's connection and learn steps to support both gut and brain health. Register at: https://bit.ly/4qhsHsO #Alzheimers #BrightFocusFoundation #ZoomInAlz

Thanks to donor support, we're funding bold projects like Dr. Joe Herdy's—exploring how genetics and inflammation intersect in Alzheimer's disease. Together, we’re building a future with better treatments and more hope. 💙 Discover his story: https://bit.ly/46QVIUq

🔬 Research into macular degeneration is advancing fast—from earlier detection to new treatments. Drs. Bovenkamp and Rossi discuss the projects making an impact and where the field is headed next. Listen to our full Macular Chat: https://bit.ly/3JaiRrH

Electronic implants in the retina or brain can restore partial vision in people who have lost the light-sensing cells in their eyes. This technology is offering hope to those with severe vision loss due to diseases like age-related macular degeneration (AMD). Learn more: https://bit.ly/3KUJr8J

🔬 Restoring vision with eye transplants has long been out of reach—but BrightFocus-funded research is changing that. Dr. Jason Meyer's work may not only help restore sight lost to glaucoma, but could reshape what we thought possible in vision science. Find out more. ⤵️

That's a wrap on Glaucoma Fast Track 2025! Researchers from around the world gathered in Atlanta to learn from experts, present their work & build networks that will drive glaucoma research forward. Breakthroughs happen when talented researchers get the mentorship, resources & community they need.

Team BrightFocus Foundation is on the ground in Atlanta for our #GlaucomaFastTrack program, the official pre-symposium workshop to the ISER/BrightFocus Glaucoma Symposium. Glaucoma Fast Track brings together top researchers from across the globe to accelerate vision research. 💪 🔬

Tune in today (Oct 8) for our next Glaucoma Chat featuring Dr. Astrid Werner to learn what causes dry eye, how to recognize the symptoms, and effective treatment options—including preservative-free drops, artificial tears, and eyelid care routines. 🔊 Listen live: https://bit.ly/3KzA0eK.

Join us for our next Glaucoma Chat on Wednesday, Oct 8, featuring Dr. Astrid Werner to learn what causes dry eye, how to recognize the symptoms, and effective treatment options—including preservative-free drops, artificial tears, and eyelid care routines. Register today: https://bit.ly/46v9zQ2.

Tune in to tomorrow's episode of Zoom In on Dementia & Alzheimer’s. Dr. Laura Baker will share results from the U.S. POINTER trial—the largest study of its kind to test how lifestyle changes impact brain health: https://www.youtube.com/live/eh7EwYm11zY

📢 Our 2025 annual report is here! Thanks to donors, BrightFocus Foundation funded 186 research grants in 16 countries advancing the fight against Alzheimer's, macular degeneration & glaucoma. Read the full report: https://bit.ly/4nD6rrp

Can your lifestyle choices protect your memory? New findings from the U.S. POINTER trial suggest they can. Join us on Oct 2 to learn how combining key lifestyle strategies could be your best defense against dementia. Register: https://bit.ly/4pHZNle

Can doctor's slow geographic atrophy progression? Retina specialist Dr. Sara Fard has answers. Join our Macular Chat tomorrow (Sept. 24) at 1 p.m. ET. Listen live 🔊 https://bit.ly/46cyZlj

📢 BrightFocus Foundation is proud to welcome Jimmy Liu, PhD, as our new Director of Vision Science Programs! Dr. Liu brings deep expertise in eye disease research and a passion for advancing the next generation of treatments for macular degeneration and glaucoma. Read more: https://bit.ly/4mjop0x

Join us for our Sept 24 Macular Chat featuring Dr. Sara Fard, a retina specialist at Illinois Retina Associates, as she explains the benefits of sustained GA treatment, including slowing the rate of vision loss, protecting retinal tissue & supporting visual function. Details: https://bit.ly/4miH393

Glaucoma affects more than 4 million Americans & can only be diagnosed through a dilated eye exam—yet too many people don’t know they have glaucoma until irreversible vision loss has occurred. Our new "Stop Glaucoma” PSA encourages everyone to protect their sight: https://bit.ly/46q9jQS

Age-related macular degeneration (AMD) affects millions and can only be diagnosed through eye exams. Many don't know they have it until irreversible vision loss has already occurred. Watch our new PSA featuring first-person accounts of vision loss. Join us to #StopAMD: https://bit.ly/4na8QK1

Dr. Keith Hengen is taking a new approach to Alzheimer's research by studying early brain activity patterns during sleep. Join us on Sept 18 at noon ET on Instagram Live for a conversation about his Alzheimer's research + answers to your questions. Read more: https://bit.ly/3Kme46I.

Despite high risk, people with Down Syndrome are excluded from Alzheimer's trials. Inclusive research will increase their life expectancy by 5 years & reduce care costs. Read about the research co-funded by BrightFocus Foundation and published in @alzdemjournals.bsky.social: https://bit.ly/42rTojT

Attention scientists: Join BrightFocus Foundation for #AlzFastTrack—an official pre-meeting for #SfN25. ⌛ Registration closes Sept 15, 2025! Learn from experts in the Alzheimer’s and dementia field, network, and grow your grant writing skills. Register: https://bit.ly/4gcAMtQ

What if vision loss from glaucoma could be restored? Find out today at 1pm ET, when Dr. Lucy Shen of Mass. Eye and Ear breaks down where the science stands on vision restoration. Watch our livestream to learn about the latest advances in optic nerve regeneration and stem cell and gene therapies. ⤵️

A treatment being tested in clinical trials for mild-to-moderate Alzheimer's using personalized, non-invasive brain stimulation shows promise in slowing cognitive decline and preserving daily function. Read about Dr. Giacomo Koch's research: https://bit.ly/41Jr4JG 🧠 🔬

Dr. Roberta Diaz Brinton from the @uazhealthsciences.bsky.social discusses the ReGenBRAIN clinical trial and the potential for harnessing the brain's natural growth processes for the treatment of Alzheimer’s. Learn more & watch our full episode: https://bit.ly/3JQKxSw #Science #Health #Alzheimers

The connection between sugar and age-related macular degeneration is stronger than you might think. Research indicates that high-glycemic foods like soda, candy, white bread, and pasta create inflammatory compounds that can harm your retina. Read more: https://bit.ly/465PeiL.

We're hosting an Instagram Live on Sept 18 at 12 pm ET with Dr. Sharyn Rossi, senior director neuroscience at BrightFocus Foundation & Dr. Keith Hengen of @uwdeptmedicine.bsky.social. We'll cover sleep and brain health, new research & answer your questions live on Instagram. Set your reminder. 🔔

Join us for an update on the HOPE Study, which is testing whether non-invasive 40 Hz light and sound stimulation can slow Alzheimer’s. We’ll explore what the science shows so far and take your questions about this and other non-invasive dementia treatments. Register now: https://bit.ly/3HZvJR0.

📢 #BreakingNews: The FDA has approved an at-home version of Leqembi, the first anti-amyloid therapy individuals can self-administer with a weekly injection. This new option makes treatment more convenient for families & continues to target harmful brain plaques that drive Alzheimer’s. Read more. ⤵️